Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study.

[1]  S. Anker,et al.  Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction. , 2013, International journal of cardiology.

[2]  L. Rohde,et al.  IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. , 2013, International journal of cardiology.

[3]  T. Richards,et al.  Expansion of the red cell distribution width and evolving iron deficiency as predictors of poor outcome in chronic heart failure. , 2013, International journal of cardiology.

[4]  G. Weiss.  Monitoring iron therapy in chronic heart failure , 2013, European journal of heart failure.

[5]  P. Ponikowski,et al.  The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR‐HF study , 2013, European journal of heart failure.

[6]  P. Ponikowski,et al.  Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial , 2013, European journal of heart failure.

[7]  J. Verdú,et al.  Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status , 2013, European journal of heart failure.

[8]  C. Brugnara,et al.  Red cell indices in classification and treatment of anemias: from M.M. Wintrobes's original 1934 classification to the third millennium , 2013, Current opinion in hematology.

[9]  P. Ponikowski,et al.  Iron deficiency in chronic heart failure: an international pooled analysis. , 2013, American heart journal.

[10]  P. Ponikowski,et al.  The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study , 2012, European heart journal.

[11]  M. Kruszewski,et al.  Myocardial iron homeostasis in advanced chronic heart failure patients. , 2012, International journal of cardiology.

[12]  M. Cowie.  Person-centred care: more than just improving patient satisfaction? , 2012, European heart journal.

[13]  P. Ponikowski,et al.  Beyond the cardiorenal anaemia syndrome: recognizing the role of iron deficiency , 2012, European journal of heart failure.

[14]  A. Elhendy,et al.  Tissue Doppler and Strain Rate Imaging Detect Improvement of Myocardial Function in Iron Deficient Patients with Congestive Heart Failure after Iron Replacement Therapy , 2012, Echocardiography.

[15]  Inger Ekman,et al.  Effects of person-centred care in patients with chronic heart failure: the PCC-HF study , 2011, European heart journal.

[16]  P. Ponikowski,et al.  Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure. , 2011, Journal of cardiac failure.

[17]  P. Poole‐Wilson,et al.  Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. , 2011, Journal of the American College of Cardiology.

[18]  C. D. dos Remedios,et al.  Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure. , 2011, Journal of the American College of Cardiology.

[19]  O. Garin,et al.  Validation of the Spanish version of the Kansas city cardiomyopathy questionnaire. , 2011, Revista espanola de cardiologia.

[20]  T. Ganz,et al.  Detection, evaluation, and management of iron-restricted erythropoiesis. , 2010, Blood.

[21]  P. Ponikowski,et al.  Iron deficiency: an ominous sign in patients with systolic chronic heart failure. , 2010, European heart journal.

[22]  P. Ponikowski,et al.  Molecular changes in myocardium in the course of anemia or iron deficiency. , 2010, Heart failure clinics.

[23]  D. J. Veldhuisen,et al.  Effects of alagebrium, an advanced glycation end‐product breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial , 2010, European journal of heart failure.

[24]  G. Felker,et al.  Red blood cell distribution width and 1‐year mortality in acute heart failure , 2010, European journal of heart failure.

[25]  P. Ponikowski,et al.  Ferric carboxymaltose in patients with heart failure and iron deficiency. , 2009, The New England journal of medicine.

[26]  P. Ponikowski,et al.  Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology , 2009, European journal of heart failure.

[27]  D. Moser,et al.  Quality of life in patients with heart failure: ask the patients. , 2009, Heart & lung : the journal of critical care.

[28]  R. Califf,et al.  Changing preferences for survival after hospitalization with advanced heart failure. , 2008, Journal of the American College of Cardiology.

[29]  R. I. Usmanov,et al.  Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. , 2008, Journal of nephrology.

[30]  P. Ponikowski,et al.  Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. , 2007, Journal of the American College of Cardiology.

[31]  P. Duarte,et al.  Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. , 2007, Journal of the American College of Cardiology.

[32]  J. Spertus,et al.  Summary health status measures in advanced heart failure: relationship to clinical variables and outcome. , 2007, Journal of cardiac failure.

[33]  J. Wish.  Assessing iron status: beyond serum ferritin and transferrin saturation. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[34]  V. Froelicher,et al.  Association of functional and health status measures in heart failure. , 2006, Journal of cardiac failure.

[35]  D. J. Veldhuisen,et al.  Heart failure programmes in countries with a primary care‐based health care system. Are additional trials necessary? Design of the DEAL‐HF study , 2005, European journal of heart failure.

[36]  P. Hinton,et al.  Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. , 2004, The American journal of clinical nutrition.

[37]  Karl Swedberg,et al.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.

[38]  S. Silver,et al.  Heart Failure , 1937, The New England journal of medicine.

[39]  Christian Thomas,et al.  Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. , 2002, Clinical chemistry.

[40]  W. Herzog,et al.  Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables , 2002, Heart.

[41]  J. Haas,et al.  Iron-Deficiency Anemia: Reexamining the Nature and Magnitude of the Public Health Problem Iron Deficiency and Reduced Work Capacity: A Critical Review of the Research to Determine a Causal Relationship 1,2 , 2001 .

[42]  J. Beilby,et al.  Transferrin index: an alternative method for calculating the iron saturation of transferrin. , 1992, Clinical chemistry.

[43]  T. Rector.  Patients' self-assessment of their congestive heart failure : Content, reliability, and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire , 1987 .